| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Surgery, School of Medicine, University of California, Los Angeles, California 90024
Immunization of lymphocytes by 17 cultured human tumor lines and subsequent killing of the specific tumor target has been demonstrated. Killing, measured by the release of 51Cr from labeled target cells, was greater for the specific tumor lines in most instances than for the non-specific lines tested or for phytohemagglutinin-stimulated lymphocytes. In addition, lymphocytes immunized by human tumor cell lines were more reactive against the tumor lines than were lymphocytes immunized by allogeneic lymphocytes. Although immunization to HL-A antigens cannot be established as yet, simple immunization to tumor antigens cannot be excluded.
1 This work was supported by Contract NIH-NCI 72-2008 within The Virus Cancer Program of the National Cancer Institute.
2 To whom reprints requests should be addressed, at the Department of Surgery, School of Medicine, University of California, Los Angeles, Calif. 90024.
Received 8/10/73. Accepted 9/28/73.
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |